Alzheimer's Drug Divides Doctors Over Cost-Benefit in Portugal

A new medication capable of delaying Alzheimer's progression for several months is causing debate among doctors in Portugal due to its high cost and lack of coverage by the national health service.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

observadorPortuguese1h ago

O medicamento que atrasa o Alzheimer, mas divide os médicos

Medicamento atrasa, durante alguns meses, a progressão do Alzheimer em cerca de 35%. Mas custo é elevado e o SNS ainda não o comparticipa. Médicos divididos quanto ao custo-benefício.

Read full article →

PERSPECTA

PERSPECTA

Alzheimer's Drug Divides Doctors Over Cost-Benefit in Portugal

Sources

O medicamento que atrasa o Alzheimer, mas divide os médicos

Related Stories

Heavy Rains and Thunderstorms Expected in Zambales After Heatwave

Canadian Passenger from MV Hondius Confirmed Positive for Hantavirus

Switzerland Plans Ban on Unhealthy Food Advertising to Combat Childhood Obesity

Zurich University Hospital Tightens Rules Following Maisano Heart Surgery Scandal

PERSPECTA